Assuntos
Artrite Juvenil/tratamento farmacológico , Glucocorticoides/administração & dosagem , Glucocorticoides/uso terapêutico , Síndrome de Nicolau/diagnóstico , Síndrome de Nicolau/etiologia , Anticoagulantes/uso terapêutico , Criança , Desbridamento , Humanos , Oxigenoterapia Hiperbárica , Injeções Intra-Articulares/efeitos adversos , Masculino , Síndrome de Nicolau/terapia , Transplante de Pele , Resultado do Tratamento , Vasodilatadores/uso terapêuticoRESUMO
Recent studies support the presence of an inflammatory response during the treatment of diabetic ketoacidosis (DKA). The objectives of this study were to monitor the complement activation products C3a, C4a, Bb, and C5b-9 prior to, during, and after correction of DKA. All patients had increased levels of C3a at 6-8 h and 24 h (P<0.05). C4a was increased in only one patient. Bb showed an upward trend at 6-8 h, and was significantly elevated at 24 h (P<0.05); sC5b-9 was elevated in all patients prior to treatment or in the first 6-8 h of treatment. Results indicate that the alternative pathway may be the primary pathway of activation. These results extend the observation that both DKA and its treatment produce varying degrees of immunologic stress during the time when acute complications are most likely to occur.
Assuntos
Ativação do Complemento/imunologia , Proteínas do Sistema Complemento/imunologia , Cetoacidose Diabética/imunologia , Adolescente , C3 Convertase da Via Alternativa do Complemento , Complemento C3a/metabolismo , Complemento C3b , Complemento C4a/metabolismo , Complexo de Ataque à Membrana do Sistema Complemento/metabolismo , Diabetes Mellitus Tipo 1/imunologia , Cetoacidose Diabética/sangue , Cetoacidose Diabética/terapia , Feminino , Humanos , Masculino , Fragmentos de Peptídeos/sangueRESUMO
Paraneoplastic autoimmune multiorgan syndrome, also known as paraneoplastic pemphigus, has been observed only rarely among children. We describe a 10-year-old boy with typical clinical and histologic findings of paraneoplastic pemphigus associated with Castleman's disease. His disease was refractory to resection of the tumor and aggressive combination immunosuppressive therapies. The patient died 1 year after presentation, as a result of complications of bronchiolitis obliterans. This case is unusual because of the young age of the patient.